Live Breaking News & Updates on மிட்செல் க்ரோனன்பெர்க்
Stay updated with breaking news from மிட்செல் க்ரோனன்பெர்க். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
La Jolla News Nuggets: LJI president, art committee, 'Hometown Heroes,' $3 million honors, UCSD studies, more lajollalight.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lajollalight.com Daily Mail and Mail on Sunday newspapers.
Collaboration Explores Therapies for Autoimmune Diseases multiplesclerosisnewstoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from multiplesclerosisnewstoday.com Daily Mail and Mail on Sunday newspapers.
Cytocom, Inc. and La Jolla Institute for Immunology Announce Five-Year Research Alliance Agreement prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Appia Bio Launches With $52 Million Series A Financing and Establishes Scientific Advisory Board Proceeds will be used to progress stem cell derived CAR-engineered invariant natural killer T cells (CAR-iNKT) to the clinic in hematological and solid tumor indications News provided by Share this article Share this article LOS ANGELES, May 11, 2021 /PRNewswire/ Appia Bio, Inc., an early stage biotechnology company developing engineered allogeneic cell therapies from hematopoietic stem cells (HSCs) for cancer patients, today announced its launch from stealth backed by $52 million Series A financing led by 8VC. Other investors included Two Sigma Ventures, among others, and participation from seed investors Sherpa Healthcare Partners and Freeflow Ventures. ....
Print Erica Ollmann Saphire, a biologist known internationally for her efforts to fight such deadly viruses as COVID-19 and Ebola, has been named president and chief executive officer of the La Jolla Institute, one of the country’s foremost private biomedical research centers. Saphire, 49, will succeed Mitchell Kronenberg, who has led LJI for nearly 20 years. He will remain as chief scientific officer. She will continue to run her lab, which serves as a global clearinghouse in the search for antibodies that might be effective against COVID-19, which has killed 2.65 million people. Her appointment means that LJI, which is small, has managed to fend off recruiters from other institutions. In the process, LJI will likely become the third local, high-ranking biomedical institute whose president is a woman. Her appointment takes effect on Sept. 1. ....